Compounding business seals cannabis deal

International medical cannabis firm MMJ PhytoTech has teamed with two strategic partners to enter the Australian market.

MMJ is listed on the Australian share market and has medical cannabis cultivation facilities in Canada, a research arm in Israel, and a subsidiary called Satipharm that  distributes a cannabinoid-based food supplement in Europe.

It has now signed a letter of intent with NSW's Fresh Therapeutics Compounding Pharmacy to import and dispense